Expression of CD44v6 and its association with prognosis in epithelial ovarian carcinomas

Pathology Research International

Volumn 2012, Issue , 2012, Pages

  Zhou, Dang Xia ^a,b   Liu, Yun Xia ^c   Xue, Ya Hong ^c  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c First Hosp of Xi'an Jiaotong Univ   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84866073353     PISSN: None     EISSN: 2042003X     Source Type: Journal    
DOI: 10.1155/2012/908206     Document Type: Article

References (18)

1. Saad A. F., Hu W., Sood A. K., Microenvironment and pathogenesis of epithelial ovarian cancer. Hormones and Cancer 2010 1 6 277 290 2-s2.0-78650223296 10.1007/s12672-010-0054-2
2. McCluggage W. G., Morphological subtypes of ovarian carcinoma: a review with emphasis on new developments and pathogenesis. Pathology 2011 43 5 420 432 10.1097/PAT.0b013e328348a6e7
3. Eyler C. E., Telen M. J., The Lutheran glycoprotein: a multifunctional adhesion receptor. Transfusion 2006 46 4 668 677 2-s2.0-33645285018 10.1111/j.1537-2995.2006.00779.x
4. Jijiwa M., Demir H., Gupta S., Leung C., Joshi K., Orozco N., Huang T., Yildiz V. O., Shibahara I., de Jesus J. A., Yong W. H., Mischel P. S., Fernandez S., Kornblum H. I., Nakano I., CD44V6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS ONE 2011 6 9, article e24217 10.1371/journal.pone.0024217
5. Afify A., Purnell P., Nguyen L., Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion. Experimental and Molecular Pathology 2009 86 2 95 100 2-s2.0-62949171989 10.1016/j.yexmp.2008.12.003
6. Yu P., Zhou L., Ke W., Li K., Clinical significance of pAKT and CD44v6 overexpression with breast cancer. Journal of Cancer Research and Clinical Oncology 2010 136 8 1283 1292 2-s2.0-77954601345 10.1007/s00432-010-0779-x
7. Ahmed F. E., Molecular markers that predict response to colon cancer therapy. Expert Review of Molecular Diagnostics 2005 5 3 353 375 2-s2.0-18844395361 10.1586/14737159.5.3.353 (Pubitemid 40686096)
8. Wan X. B., Pan Z. Z., Ren Y. K., Ding P. R., Chen G., Wan D. S., Expression and clinical significance of metastasis-related tumor markers in colorectal cancer. Chinese Journal of Cancer 2009 28 9 950 954
9. Da Cunha C. B., Oliveira C., Wen X., Gomes B., Sousa S., Suriano G., Grellier M., Huntsman D. G., Carneiro F., Granja P. L., Seruca R., De novo expression of CD44 variants in sporadic and hereditary gastric cancer. Laboratory Investigation 2010 90 11 1604 1614 2-s2.0-78049336816 10.1038/labinvest.2010.155
10. Yasui W., Oue N., Phyu P. A., Matsumura S., Shutoh M., Nakayama H., Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 2005 8 2 86 94 2-s2.0-18544362183 10.1007/s10120-005-0320-0 (Pubitemid 40655517)
11. Affy A. M., Tate S., Durbin-Johnson B., Rocke D. M., Konia T., Expression of CD44s and CD44v6 in lung cancer and their correlation with prognostic factors. International Journal of Biological Markers 2011 26 1 50 57 10.5301/JBM.2011.6291
12. Situ D., Long H., Lin P., Zhu Z., Wang J., Zhang X., Xie Z., Rong T., Expression and prognostic relevance of CD44v6 in stage I non-small cell lung carcinoma. Journal of Cancer Research and Clinical Oncology 2010 136 8 1213 1219 2-s2.0-77954602453 10.1007/s00432-010-0771-5
13. Bouda J., Boudova L., Hes O., Havir M., Tempfer C., Kohlberger P., Svoboda T., Rokyta Z., Speiser P., CD44v6 as a prognostic factor in cervical carcinoma FIGO stage IB. Anticancer Research 2005 25 1 B 617 622 2-s2.0-16344381127 (Pubitemid 40470072)
14. Zhang R., Song Y., Gao W. J., Zhang X., Zuo J., Lei C. Z., Wang Y., Expression of P53, COX2 and CD44V6 in early-stage squamous carcinoma of cervix with lymph vascular space invasion positive and negative and its relationship with prognosis. Zhonghua Yi Xue Za Zhi 2009 89 47 3341 3345 2-s2.0-77951625764
15. Afify A. M., Craig S., Paulino A. F. G., Stern R., Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium. Annals of Diagnostic Pathology 2005 9 6 312 318 2-s2.0-27944475150 10.1016/j.anndiagpath.2005.07.004 (Pubitemid 41676878)
16. Liu Y. J., Yan P. S., Li J., Jia J. F., Expression and significance of CD44s, CD44v6 and nm23mRNA in human cancer. World Journal of Gastroenterology 2005 11 42 6601 6606 (Pubitemid 43072697)
17. Sun Y., He H., Ma Q., Wang X. Y., Yang L., He D. L., Clinical evaluation of BTAstat, NMP22, HA, survivin, CD44v6, VEGF and VUC in bladder cancer diagnosis. Zhonghua Yi Xue Za Zhi 2005 85 35 2507 2512 2-s2.0-25844526464 (Pubitemid 41388229)
18. Yamada Y., Itano N., Narimatsu H., Kudo T., Hirohashi S., Ochiai A., CD44 variant exon 6 expressions in colon cancer assessed by quantitative analysis using real time reverse transcriptase-polymerase chain reaction. Oncology Reports 2003 10 6 1919 1924 2-s2.0-1642391566